HENRY SCHEIN, INC. vs QXO, Inc., two Distribution stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Dental and medical supply is Henry Schein's business, a thin 2.95% margin that still reliably earns 10.08% on equity; QXO is a building-products rollup in the red at a negative 5.07%, growing by acquisition. Schein trades at 25.7 times earnings and 2.52 times book, an established healthcare distributor; QXO at no clean multiple and 1.30 times book, valued on its buildout. Schein converts a healthy 4.51% free cash, QXO 1.47% amid its spending. The pair contrasts a mature, low-margin distributor with an unprofitable young one: Schein's healthcare niche earns modest but real returns, QXO is still assembling the scale that might one day earn them, one measurable today, the other a wager on tomorrow.
Comparison updated 2026-07-11.
| Metric | HSIC | QXO |
|---|---|---|
| Price | $84.37 | $14.98 |
| Market cap | $9.8B | $11.2B |
| Sector | Distribution | Distribution |
| Stage | Mature | Growth |
| Implied growth (priced in) | +5.1% | — |
| P/E | 25.5 | — |
| P/B | 2.50 | 1.10 |
| P/S | 0.73 | 1.30 |
| EV/EBITDA | 10.9 | — |
| Revenue growth | +5.6% | +200.0% |
| Gross margin | 31.8% | 23.7% |
| Operating margin | 5.4% | -14.6% |
| Net margin | 3.0% | -6.0% |
| Return on equity | 10.1% | -5.1% |
| Return on assets | 3.5% | -3.1% |
| Return on invested capital | 10.5% | -2.7% |
| FCF yield | 4.5% | 1.8% |
| Debt / equity | 0.27 | 0.30 |
| Current ratio | 1.36 | 3.33 |
| Altman Z (solvency) | 2.68 | 1.76 |
| Piotroski F (quality) | 4 / 9 | 3 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.